Vabysmo(Faricimab-svoa) Side Effects

Common adverse reactions include cataract and conjunctival hemorrhage, with potential serious ocular events.

Side Effects

The most common adverse reactions reported in clinical trials are cataract (15%) and conjunctival hemorrhage (8%). Other events include vitreous detachment, increased intraocular pressure, and eye pain. Serious reactions such as endophthalmitis, retinal detachments, and retinal vasculitis may occur. Patients should report symptoms like vision changes, eye pain, or redness immediately.

Faricimab-svoa(Vabysmo)
Treatment of neovascular age-related macular degeneration, diabetic macular edema, and macular edema secondary to retinal vein occlusion.
RELATED ARTICLES
/ 0
0 in total
Contact Medical Consultant
Global Drug Search
Clinical recruitment
overseas medical treatment
Remote consultation
Note: Our medical consultant will contact you as soon as possible. We promise to strictly protect your privacy.
Click to submit medical consultant
Contact Us
Mailbox:Info@Lucius.La
Welcome To Consult
Ucius Pharmaceuticals (Lao) Co.,Ltd All Rights Reserved